Table 1. Clinical and pathologic features of the HCC cohort categorized by the establishment of tumoroids.
| No. | Sex | Age (years) | Edmondson grade | Etiology | ALBI grade | Ishak score | AFP (ng/mL) | Growth pattern | Tumor size (mm × mm) | Tumoroids |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 57 | III | HBV | 1 | 3 | 413 | Solid | 97×73, 25×22 | Yes |
| 2 | M | 64 | III | HBV | 1 | 3 | 3,700 | Solid-trabecular | 29×17 | Yes |
| 3 | M | 67 | III | HBV | 1 | 4 | 3,479 | Solid-trabecular | 23×17 | Yes |
| 4 | M | 63 | III | HBV | 2 | 2 | 218 | Solid | 31×19 | Yes |
| 5 | M | 51 | III | HBV, ALD | 2 | 5 | 20,053 | Solid-trabecular | 68×71 | No |
| 6 | F | 46 | I | HBV | 1 | 4 | 498 | Solid | 63×31 | No |
| 7 | M | 42 | II | HBV | 2 | 2 | 32,727 | Solid | 95×70, 17×15 | No |
| 8 | M | 68 | II | HBV | 1 | 4 | 2,465 | Trabecular | 73×42 | No |
| 9 | M | 46 | III | HBV | 1 | 5 | 4,164 | Solid-trabecular | 91×64, 20×16 | No |
| 10 | M | 54 | II | ALD | 1 | 4 | 13.4 | Solid-pseudoglandular | 44×39 | No |
| 11 | M | 58 | II | HBV | 1 | 4 | 213 | Solid-trabecular | 79×30 | No |
| 12 | M | 59 | II | HBV | 1 | 5 | 1.19 | Solid | 21×17 | No |
| 13 | M | 60 | III | Unknown | 2 | 2 | 153 | Solid-trabecular | 54×32, 22×13 | No |
| 14 | M | 61 | II | HBV | 1 | 3 | 5.11 | Solid | 29×21 | No |
ALBI, albumin-bilirubin; AFP, α-fetoprotein; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; ALD, alcoholic liver disease.